Not the same trial

The BI trial started at the same time as the DF trial... is that correct?

If true, can we make any assumption about tumor shrinkage at this point in the DF trial? -Tails

The DF/BI Phase 1 clinical trial is on humans.

The PR today was for a separate pre-clinical research study of Kevetrin with  sunitinib in lab animals, most likely mice, not a human clinical trial.

Cellceutix did several pre-clinical studies with excellent results. This is the first PR of pre-clinical studies outside of Cellceutix, and in this case in combination with a Pfizer drug.

The end of year update referenced the pre-clinical research at the University of Bologna that concluded prior to this, but only hinted at the results. I expect that may be because the University intends to publish.

Tumor shrinkage news from the human clinical trial would be news on a vastly greater scale.